CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-05 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −93 | $5.10 | $474 | 26,397 |
| 2020-05-05 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −113 | $5.10 | $576 | 18,033 |
| 2020-05-05 | MANZO MICHAEL P. VP of Engineering | Shares withheld for taxes | −93 | $5.10 | $474 | 18,076 |
| 2020-05-05 | FROM STEPHEN President and CEO | Shares withheld for taxes | −617 | $5.10 | $3K | 82,330 |
| 2020-04-02 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −122 | $4.97 | $606 | 18,146 |
| 2020-04-02 | FROM STEPHEN President and CEO | Shares withheld for taxes | −670 | $4.97 | $3K | 82,947 |
| 2020-04-02 | MANZO MICHAEL P. VP of Engineering | Shares withheld for taxes | −122 | $4.97 | $606 | 18,169 |
| 2020-04-02 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −122 | $4.97 | $606 | 26,490 |
| 2020-03-09 | FROM STEPHEN President and CEO | Shares withheld for taxes | −712 | $5.00 | $4K | 83,617 |
| 2020-03-09 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −130 | $5.00 | $650 | 18,268 |
| 2020-03-09 | MANZO MICHAEL P. VP of Engineering | Shares withheld for taxes | −130 | $5.01 | $651 | 18,291 |
| 2020-03-09 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −130 | $5.01 | $651 | 26,612 |
| 2020-02-14 | FROM STEPHEN President and CEO | Grant or award | +20,000 | 84,329 | ||
| 2020-02-14 | FROM STEPHEN President and CEO | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-02-14 | Romano Sarah Chief Financial Officer | Grant or award | +10,000 | 26,742 | ||
| 2020-02-14 | Romano Sarah Chief Financial Officer | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-02-14 | HANCOCK THOMAS Director | Grant or award · Stock Option (right to buy) | +3,333 | 3,333 | ||
| 2020-02-14 | TYLE PRAVEEN Director | Grant or award · Stock Option (right to buy) | +3,333 | 3,333 | ||
| 2020-02-14 | CHANEY PAUL G Director | Grant or award · Stock Option (right to buy) | +3,333 | 3,333 | ||
| 2020-02-14 | GOLDBERG MORTON Director | Grant or award · Stock Option (right to buy) | +3,333 | 3,333 |
Page 11 of 13 · 244 trades